期刊
JOURNAL OF NEUROINFLAMMATION
卷 19, 期 1, 页码 -出版社
BMC
DOI: 10.1186/s12974-022-02579-8
关键词
COVID-19; SARS-CoV-2; Neuroinvasion; BBB; Cognitive
资金
- National Natural Science Foundation of China [82071190, 82101269]
COVID-19, caused by SARS-CoV-2, may invade the brains of patients and cause cognitive impairment. The virus can affect cranial nerves and potentially interact with the brain through infected nerve endings and the blood-brain barrier.
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to a global pandemic. Although COVID-19 was initially described as a respiratory disease, there is growing evidence that SARS-CoV-2 is able to invade the brains of COVID-19 patients and cause cognitive impairment. It has been reported that SARS-CoV-2 may have invasive effects on a variety of cranial nerves, including the olfactory, trigeminal, optic, and vagus nerves, and may spread to other brain regions via infected nerve endings, retrograde transport, and transsynaptic transmission. In addition, the blood-brain barrier (BBB), composed of neurovascular units (NVUs) lining the brain microvasculature, acts as a physical barrier between nerve cells and circulating cells of the immune system and is able to regulate the transfer of substances between the blood and brain parenchyma. Therefore, the BBB may be an important structure for the direct and indirect interaction of SARS-CoV-2 with the brain via the blood circulation. In this review, we assessed the potential involvement of neuroinvasion under the SARS-CoV-2 infection, and the potential impact of BBB disorder under SARS-CoV-2 infection on cognitive impairment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据